RNA interference, DNA methylation, and gene silencing: a bright future for cancer therapy?
Lancet Oncol
.
2004 Nov;5(11):653-4.
doi: 10.1016/S1470-2045(04)01604-3.
Authors
Charles Swanton
1
,
Barbara Nicke
,
Julian Downward
Affiliation
1
Signal Transduction Laboratory, Cancer Research UK London Research Institute, London, UK.
PMID:
15522650
DOI:
10.1016/S1470-2045(04)01604-3
No abstract available
MeSH terms
Antineoplastic Agents / pharmacology
Biotechnology / trends
Breast Neoplasms / drug therapy
Breast Neoplasms / genetics
DNA Methylation*
Gene Silencing*
Genes, erbB-2
Humans
RNA Interference*
Substances
Antineoplastic Agents